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Abstract Phosphoglucose isomerase catalyzes the isomeriza-
tion between glucose 6-phosphate and fructose 6-phosphate in
cytoplasm, and functions as autocrine motility factor and
neuroleukin outside the cells. A phosphoglucose isomerase from
Bacillus stearothermophilus (pgiA) was subjected to mutagenesis
study to address the catalytic function of the conserved anionic
residues and those probably interacting with the phosphate group
of substrates. The results suggest that Glu290 works concertedly
with His311 as a general acid^base pair to initiate the
isomerization step, and Glu150 assists the base function of
His311. The conserved loop structure consisting of Gly205^
Gly206^Arg207 plays a critical role for the recognition of
substrates. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Phosphoglucose isomerase (EC 5.3.1.9) is a protein with
multiple functions. As being a glycolytic enzyme, it catalyzes
the interconversion of glucose 6-phosphate and fructose 6-
phosphate in the glycolysis and gluconeogenesis pathways.
The de¢ciency of this metabolic enzyme a¡ects the metabo-
lism of red blood cells and consequently leads to non-spher-
ocytic hemolytic anemia [1]. Several mutations associated with
this hereditary disease have been identi¢ed [2^4]. Outside the
cells, it also functions as a neuroleukin [5,6], autocrine motil-
ity factor (AMF) of tumor cells [7,8], and the di¡erentiation
and maturation mediator (DMM) for human myeloid leuke-
mia cells [9]. Given the involvement of phosphoglucose iso-
merase in so many di¡erent biological processes, its structure^
function relationship is an important issue.
To achieve the aim, two isozymes of the enzyme from Ba-
cillus stearothermophilus (pgiA and pgiB) have been studied in
series experiments. PgiA and pgiB share 70% identity in ami-
no acid sequence and have similar properties in terms of en-
zymatic activity and thermostability. Both pgiA and pgiB
were puri¢ed and crystallized [10]; furthermore, the 3-D struc-
tures of pgiB [11] and its complex with 5-phosphoarabinonate
[12] have been determined. Since 5-phosphoarabinonate be-
haved as a transition-state inhibitor of the enzyme [13], the
active site of the complex probably resumes a transition-state-
like con¢guration. In spite of the bacteria origin, the phos-
phoglucose isomerase from B. stearothermophilus was capable
of functioning as neuroleukin and AMF in vitro [11]. Accord-
ing to the crystal structure, pgiB is in a dimeric form. Each
subunit is composed of a large and a small globular domain
with similar structure in which a L-sheet core is surrounded by
K-helices. The active site is located within the two globular
domains and the interface between the two subunits. Recently,
the structure of phosphoglucose isomerase from rabbit muscle
was also solved [14]. The overall fold of the rabbit muscle
phosphoglucose isomerase is very similar to that of pgiB.
Superposition of the two structures reveals no signi¢cant ami-
no acid shifts at and around the active site and no signi¢cant
changes in interdomain or intersubunit interfaces. Nonethe-
less, the inhibitors, 5-phosphoarabinonate for pgiB and 6-
phosphogluconate for the rabbit enzyme, bound in di¡erent
dispositions in the active site. The phosphate group of the
former lies in the bottom of the active site cleft, while that
of the latter occupies the entrance of the active site.
According to numerous kinetic studies [15^17], the catalytic
mechanism of phosphoglucose isomerase has long been pro-
posed to include steps of (a) binding of cyclic form of sub-
strates, (b) ring opening of substrates, (c) base-catalyzed iso-
merization via a cis-enediol intermediate which is the rate-
limiting step, (d) closure of products, and (e) release of prod-
ucts. The temperature dependence of pKa values, determined
from pH pro¢les of enzymatic activity, suggested critical roles
of a protonated lysine and a non-protonated imidazole in the
catalysis [18]. Mutagenesis has been carried out in pgiA to
address the function of several conserved amino acids. Sub-
stitution of alanine for Arg207 and Lys425 (Arg202 and
Lys420, respectively, in pgiB; hereafter, residues in parenthe-
ses indicated the corresponding position in pgiB) resulted in a
105- and 400-fold decrease, respectively, in the catalytic e⁄-
ciency (kcat/KM) of the enzyme [19]. Mutational data also
suggested the critical role of His311 (His306) [20]. The pKa
value of His311, calculated from the titration of the inactiva-
tion rate constant of pgiA by N-bromoacetyl ethanolamine,
supports the base function of His311. In this study, we con-
tinue to investigate the contributions of the other active-site
residues to substrate a⁄nity and to enzymatic activity by site-
directed mutagenesis. Focus was on the conserved anionic
amino acids and those probably interacting with the phos-
phate group of substrates. With the guidance of the active-
site architecture, the possible roles of the investigated residues
in the catalytic mechanism of phosphoglucose isomerase are
discussed.
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2. Materials and methods
2.1. Site-directed mutagenesis
Mutation was generated on plasmid pFDI132, which contains pgiA
gene, according to a PCR-based method using a pair of 5P-phosphor-
ylated divergent primers as described previously [19]. The mutagenic
nucleotide sequence was incorporated at the 5P end of one of the
divergent primers. After PCR ampli¢cation with Pfu DNA polymer-
ase, the blunt-ended linear DNA product was puri¢ed, self-ligated,
and transformed back into Escherichia coli DF2145 [(eda-zwf)15,
hisG1(Fs), pgi-7 : :Mu-1, rpsL115, hsdR2, zjj202 : :Tn10]. The desired
mutation was con¢rmed by determining the nucleotide sequence
with Amplicycles sequencing kit (Perkin-Elmer).
2.2. Production and puri¢cation of enzymes
E. coli strain DF2145, which has a disruption in its own pgi gene,
was used to produce pgiA and the variants. The culture conditions of
E. coli cells and the puri¢cation procedure for the recombinant phos-
phoglucose isomerase were as described previously [10]. All puri¢ed
pgiAs appeared homogeneously on SDS^PAGE. Similar elution be-
havior of the mutants to wild-type enzyme in each chromatographic
step suggests that each single amino acid substitution did not cause
global structural changes. Therefore, the change of kinetic constants
upon mutation is probably resulting from the local e¡ects, and may be
used to address the function of the targeted amino acid. Protein con-
centration was determined by the Coomassie blue method using the
determination kit obtained from Pierce (Rockford, IL, USA).
2.3. Enzyme activity determination
The activity catalyzing the isomerization of fructose 6-phosphate to
glucose 6-phosphate was determined by the coupled glucose 6-phos-
phate dehydrogenase method [21]. The standard activity assay bu¡er
(1 ml) contained 20 mM potassium phosphate (pH 7.0), 2 mM
NAD, 10 units of glucose 6-phosphate dehydrogenase, and varied
amount of fructose 6-phosphate and pgiA. For each reaction condi-
tion, the assay was repeated at least twice by varying the amount of
pgiA to assure that pgiA is always the limiting factor for the accel-
eration rate of NADH. For determining the activity pH pro¢le, imi-
dazole bu¡er was used from pH 6 to 7.5, Tricine bu¡er from 8.0 to
8.5, and glycine bu¡er for pH 9.0. The steady-state kinetic constants,
KM and Vmax, were determined from the Lineweaver^Burk and the
Eadie^Hofstee plots. The catalytic constant, kcat, was calculated from
the equation Vmax = kcatU[E]0, where [E]0 is the molar concentration
of the monomer of phosphoglucose isomerase.
3. Results and discussion
3.1. Mutation of the conserved anionic residues
Genes encoding phosphoglucose isomerase have been
cloned from a variety of organisms ranging from bacteria,
plants to mammals. Comparison of their deduced amino
acid sequences reveals several homologous regions including
those documented as signature patterns ([LIVM]-G-G-R-
[FY]-S-[LIVM]-X-[STA]-[STA]-[LIVM]-G and [FY]-D-Q-X-
G-V-E-X-X-K) by Swiss-Prot (http://expasy.hcuge.ch/sprot/
prosite.html). Mutational analysis and a⁄nity labeling of
pgiA have suggested the important roles and the active-site
location of the conserved lysine, arginine, and histidine
(Lys144, Lys294, Lys425, Arg207, and His311 of pgiA)
[19,20]. The structures of pgiB and the rabbit enzyme con¢rm
that all homologous regions are indeed active-site constitu-
ents. To explore the importance of other conserved residues,
the anionic residues including Glu150, Glu290, Glu401,
Asp417, and Glu422 in pgiA were ¢rst subjected to site-di-
rected mutagenesis in the present study. Since s 90% amino
acids around the active site are identical between pgiA and
pgiB, the active-site architectures of pgiB (Fig. 1) should be
applicable to that of pgiA. According to this assumption,
Glu150 (Glu145) is located behind His311 (His306) with one
of its carboxylate oxygen atoms hydrogen bonding to NO2 of
His311 (His306), whose NN1 in turn is in contact with C1
carboxylate oxygen and C2 hydroxyl oxygen of 5-phospho-
arabinonate. The carboxylate of Glu290 (Glu285) contacts
another C1 carboxylate oxygen and the phosphate group of
the inhibitor. Glu401 (Glu396) is V10 Aî away from 5-phos-
phoarabinonate and doses not contribute itself directly to the
formation of the active-site surface. The side chain of Asp417
(Asp412) points outward from the active-site cavity; however,
its backbone oxygen is involved in the active-site hydrogen
bonding network by forming a hydrogen bond to the guanido
nitrogen of Arg207 (Arg202). One of the carboxylate oxygen
atoms of Glu422 (Glu417) hydrogen bonds to the amino
group of Lys425 (Lys420) which, in turn forms a hydrogen
bond to O2 of the inhibitor.
Each targeted residue was initially substituted with alanine,
and the resulting changes of the kinetic constants are shown
in Table 1. Substitution of alanine for Glu150 resulted in an
insigni¢cant change of KM and a 103-fold decrease in kcat,
suggesting that Glu150 plays a critical role in catalysis
although it is not directly in contact with substrates. In re-
sponse to mutation of Glu290, the value of KM increased V3-
Table 1
Kinetic constants of wild-type and mutant phosphoglucose isomerase
Enzyme Kfructose 6ÿPM (mM) kcat (s
31) kcat/KM (s31 mM31) vvGVa (kcal/mol)
Wild-type 0.26 (0.05)b 150 (10) 580
E150A 0.27 (0.01) 0.12 (0.02) 0.44 4.3
E150D 0.25 (0.04) 54 (10) 216
E150N 0.49 (0.01) 0.024 (0.001) 0.05
E150Qc 1 4.5U1033 4.5U1033
E290A 0.85 (0.03) 0.36 (0.02) 0.42 4.4
E290D 0.46 (0.03) 0.036 (0.003) 0.08
E290N 1.9 (0.2) 0.010 (0.001) 0.005
E290Q 1.6 (0.1) 0.46 (0.02) 0.28
E401A 0.16 (0.10) 88 (4) 550 0.03
D417A 0.25 (0.04) 16 (1) 64 1.3
E422A 0.37 (0.01) 45 (9) 120 0.95
G205L 0.42 (0.05) 71 (6) 169
G206Lc 10 4.3U1033 4.3U1034
Q418A 1.6 (0.1) 7.5 4.7 2.9
avvGV was calculated only for mutant enzymes that had alanine substitution for targeted amino acids according to equation vvGV =
3RT ln[(kcat/KM)mutant/(kcat/KM)wt].
bFigures in parentheses are the standard deviations.
cThe data are the average of only two independent experiments, due to the large amount of enzyme needed for a kinetic assay.
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fold and the catalytic e⁄ciency (kcat/KM) dropped V3 orders
of magnitude, suggesting that Glu290 plays a role primary in
stabilizing the transition-state substrate. The mutation of
Glu401 to alanine had an insigni¢cant e¡ect on kcat/KM but
a slight bene¢t for the binding a⁄nity to the ground-state
substrate. Mutation of Asp417 caused an insigni¢cant change
of KM that could be attributed to the outward orientation of
the side chain of Asp417. Nonetheless, the mutation might
result in a local conformational perturbation by a¡ecting
the disposition of the side chain of Arg207, and consequently
resulted in a V10-fold decrease of kcat. In response to the
Glu422 mutation, KM increased 1.4-fold and kcat decreased
3.3-fold. Although Glu422 is not in direct contact with sub-
strate, the Glu422 mutation may a¡ect the enzyme function
by a¡ecting the disposition of Lys425.
To better understand the roles played by Glu150 and
Glu290, these two residues were further substituted by aspar-
tate, asparagine, and glutamine. Aspartate presumably has a
similar ionic state to that of glutamate but with a shorter side
chain. On the other hand, glutamine or asparagine might have
a chance to substitute partially the function of glutamate if
the primary function of the mutated glutamate is to partici-
pate in hydrogen bond formations. The kinetic analysis of the
respective mutant enzymes (Table 1) shows that the function
of Glu150 could be ful¢lled by aspartate as evidenced by only
3-fold decrease of kcat in the mutation of Glu150 to Asp.
However, neither asparagine nor glutamine could substitute
for Glu150. These data suggest that having a negative charge
(or the ability of ionization) is the major element for Glu150
to execute its function. Gln150 or Asn150 might induce local
conformational changes by a¡ecting the disposition of nearby
active-site amino acids, and consequently further damaged the
enzymatic activity. In contrast to the results of mutations
occurred on Glu150, none of the substitutions could ful¢ll
the function of Glu290, indicating that both the ionic state
and the exact spatial position of the carboxylate group in the
active site are crucial for catalysis. Taken together with the
closeness of the carboxylate group of Glu290 to the C1 car-
boxylate oxygen of 5-phosphoarabinonate, a general acid^
base role is suggested for Glu290.
Previous mutagenesis and a⁄nity labeling studies have sug-
gested that His311 acts as a general base initiating the isomer-
ization reaction, and its ionization is responsible for the ac-
tivity change on the acidic limb of the activity pH pro¢le [20].
Glu150, being seated behind His311, seems to provide a neg-
ative charge to assist the general-base function of His311 rem-
iniscent of the aspartate^histidine pair of the catalytic triad in
serine protease [22]. If this is true, removal of the negative
charge from residue 150 would not only cause the reduction
of activity but also change the activity pH pro¢le. The Vmax of
several pgiA variants were determined within pH range 6 to 9,
and the pro¢les of log kcat vs. pH are presented in Fig. 2. In
wild-type pgiA, the kcat value increased as pH increased. The
Glu150 to Asp mutant had a similar pH pro¢le to that of
wild-type enzyme; nonetheless, Asn150 could not support
the increasing activity at higher pH conditions, indicating
that the negative charge on residue 150 has a signi¢cant in-
£uence on the pKa value of His311. In contrast to the muta-
tion of Glu150, removal of a negative charge from residue 290
caused negligible change on the activity pH pro¢le as indi-
cated by the Glu290 to alanine mutation.
The data presented above support our previous hypothesis
on the mechanism of isomerization step [13], in which His311
and Glu290 work as a general base^acid pair to prompt the
formation of cis-enediol intermediate (Fig. 3). By reversing
their roles in the subsequent step, the intermediate is then
transformed to the product. Through electrostatic interaction,
Glu150 could stabilize the partial positive charge developing
on the side chain of His311 during the isomerization step.
Glu150 also forms a hydrogen bond to His311 and may
Fig. 1. Simpli¢ed drawing of the active-site structure of pgiB com-
plexed with 5-phosphoarabinonate. The active site is composed of
amino acids from two neighboring subunits; for example, His306 is
from B subunit (labeled as B306, H), while other residues are from
the A subunit.
Fig. 3. The roles of Glu150, Glu290, and His311 of pgiA (Glu145,
Glu285, and His306 in pgiB) in the catalytic mechanism of the iso-
merization step.
Fig. 2. E¡ect of pH on the kcat value (min31) of phosphoglucose
isomerase. The activity of variant pgiA was determined at 30‡C
over the pH range 6^7.5 (imidazole bu¡er), 8.0^8.5 (Tricine bu¡er),
and 9.0 (glycine bu¡er).
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lock the imidazole ring of His311 in an optimal position for
reaction.
3.2. Mutation of the residues around the phosphate group of
5-phosphoarabinonate
According to the crystal structure of pgiB complexed with
5-phosphoarabinonate (Fig. 1), the phosphate group of sub-
strates in transition state may be surrounded by conserved
residues Gly205, Gly206, Arg207, Glu290, and Gln418
(Gly200, Gly201, Arg202, Glu285, and Gln413, respectively).
To gain more information regarding the substrate recognition
mechanism, Gly205, Gly206, and Gln418 were also targeted in
the present study. The mutation of Gly206 to leucine resulted
in an increase of KM by a factor of 38, and a decrease of kcat/
KM by a factor of six orders of magnitude (Table 1). The side
chain of Leu206 might stick into the active-site cavity and
hinder the binding of substrate throughout the catalytic path-
way. In contrast to Gly206, mutation of Gly205 caused rela-
tively minor e¡ects on the kinetic constants (Table 1). Accord-
ing to the crystal structure, the side chain of Leu205 would
have a great chance of pointing away from the active-site
cavity, and this may account for the minor mutational e¡ects.
In response to the mutation of Gln418, KM increased 6-fold
and kcat/KM decreased two orders of magnitude (Table 1)
suggesting that Gln418 has an important role for the substrate
binding and catalysis. The cavity surrounded by the conserved
loop structure Gly205^Gly206^Arg207, Glu290, and Gln418
is thus very important for the accommodations of substrates.
In general, the kcat/KM value is much more sensitive than
KM in response to mutations in this study. For example, the
reduction of the former could reach 5^6 orders of magnitude
in some cases, whereas, the most increase of the latter was
only V38-fold. This suggests that the binding energy for the
stabilization of ground-state substrate may be attributed cu-
mulatively from all surrounding amino acids so that missing
one of them does not cause drastic change in KM. However, to
be an e⁄cient catalyst, all the concerned residues must be
present and resume their optimal positions. Deletion of any
essential residue or disturbance of the active-site con¢guration
would certainly a¡ect profoundly on the catalytic ability of
phosphoglucose isomerase.
Very recently, Je¡ery et al. published a crystal structure of
rabbit phosphoglucose isomerase complexed with 5-phospho-
D-arabinonate [23]. According to the binding position of the
inhibitor, they proposed a di¡erent mechanism in which the
active-site histidine and lysine (corresponding to His311 and
Lys425 of pgiA) catalyze the opening of the cyclic form sub-
strates, and the active-site glutamate (corresponding to
Glu290 of pgiA) takes the responsibility for the isomerization.
Although the ring-opening step is important, isomerization is
the rate-limiting step [16,17]. In fact, the spontaneous ring-
opening rate constant for fructose 6-phosphate is not slow;
it could reach V19 s31 at 40‡C, pH 7.5 [24]. Therefore, the
mutations of His311 or Lys425 would not cause severe e¡ects
on the overall activity, if these two residues played roles solely
in the step of ring opening. From the kcat values of K425A
and H311A (0.44 s31 and 0.09 s31 at 30‡C, respectively)
[19,20], we believe that these two residues must also play sig-
ni¢cant roles in the step of isomerization. In this study, we
also demonstrated the importance of Glu150 that is omitted in
the mechanism proposed by Je¡ery et al. Although more bio-
chemical and structural data in the future should extend or
even modify our catalytic model of phosphoglucose isomer-
ase, the one that we proposed is consistent with most of the
current data.
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